RNA-Protein Interaction Mapping with Covalent Capture and Denaturing Washes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for detecting RNA-protein interactions, such as CLIP and RIP, struggle to differentiate between bona fide interactions that occur in vivo and those that form in solution, leading to false positives, especially when studying RNA binding proteins that bind few targets or low-level RNA transcripts.

Innovation Solution

The Covalent Linkage and Affinity Purification (CLAP) method uses genetic tagging of proteins with covalent epitope tags, allowing covalent capture on affinity resins and denaturing washes to specifically purify and map RNA-protein interactions, distinguishing in vivo from in vitro associations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods (CLIP/RIP) are used to detect RNA-protein interactions, then interaction detection is achieved, but false positives increase due to inability to differentiate in vivo from in vitro associations

Engineering Contradiction:
Improveinteraction detection accuracyVSAvoidfalse positive rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by transitioning from native conditions to denaturing conditions during the wash step. This fundamental parameter change (from physiological to denaturing environment) allows differentiation between covalently crosslinked in vivo interactions and non-covalent in vitro associations, thereby improving measurement precision and reducing false positives

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces crosslinking agents as intermediaries that mediate between the query protein and target RNA. These crosslinking agents form covalent bonds that stabilize in vivo interactions, serving as a mediator that allows subsequent denaturing washes to remove non-specific bindings while preserving true interactions

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If denaturing washes are applied to remove spurious interactions, then false positives are reduced, but bona fide interactions may be lost

Engineering Contradiction:
Improvefalse positive reductionVSAvoidloss of true interactions
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent applies preliminary action by performing crosslinking before the denaturing wash step. This preliminary crosslinking action creates covalent bonds that protect true RNA-protein interactions from being disrupted by subsequent denaturing conditions, thereby preventing loss of bona fide interactions while allowing removal of false positives

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies preliminary anti-action by using crosslinking agents to prevent the disruption of true interactions during denaturing washes. The crosslinking creates a protective covalent linkage that counteracts the denaturing effect, ensuring that genuine interactions are preserved while non-specific bindings are eliminated

Inventive Principle:
Principle #9Preliminary anti-action

3Measurement precision

If covalent tagging and affinity purification are used, then specificity of interaction mapping is improved, but device complexity increases

Engineering Contradiction:
Improveinteraction mapping specificityVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies universality by using a standardized covalent tag system that can be attached to various query proteins. This universal tagging approach, combined with a common affinity resin, provides a multi-functional platform that simplifies the overall process despite the added specificity, as the same tag-resin system can be used across different protein targets

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent introduces covalent tags as intermediaries that mediate between the query protein and the affinity resin. These tags serve as specific recognition elements that enable high-specificity purification while maintaining a relatively simple workflow, as the tag-resin interaction is highly specific and does not require complex purification conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

CLAP effectively removes spurious RNA-protein interactions that occur in solution while retaining bona fide interactions, providing a framework for accurate RNA-protein mapping and identifying true binding sites.

Implementation Method 1

applying a crosslinking agent or force to the query protein and the composition, thus crosslinking the query protein to the target moiety associated therewith

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

covalently binding the tag to a substrate, thus covalently immobilizing the query protein and crosslinked target moiety on the substrate

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 3

washing the immobilized query protein and crosslinked target moiety under denaturing conditions, in which the query protein remains immobilized on the substrate

Methodology Applied
Scientific EffectDenaturation:

Data Source

PatentUS12560608B2Detection of molecular associations
Publication Date: 2026.02.24 CALIFORNIA INST OF TECH
  • US12560608B2 patent drawing
  • US12560608B2 patent drawing
  • US12560608B2 patent drawing

AI summary

In some embodiments, methods of detecting an association between a query protein and a target moiety are described. In some embodiments, compositions are described. In some embodiments, kits are described.